In January, the FDA banned the use of Red Dye No. 3 in foods and drugs because high concentrations of the dye were shown to cause cancer in rats. In this Living Well, First Alert 4’s Taylor Holt sits down with a local doctor to dig into the ban, find out what’s next and what […]
Sarah Bauer Huang, MD, PhD, has been appointed head of the Section of Neonatal Neurology, effective July 1, 2025. Chris Smyser, MD, will step down from this position to focus on his role as associate director of the Division of Pediatric and Developmental Neurology. Smyser joined the faculty at Washington University School of Medicine in […]
A recent safety surveillance paper published in Neurology reported that of eleven pediatric patients who were treated with tenecteplase for suspected stroke, there were no instances of intracranial bleeding or other safety concerns. This study is an important first step toward further research to establish the safety and efficacy of tenecteplase for treating pediatric stroke. […]
Eight years after receiving a life-shattering diagnosis, a New Jersey mother credits an “amazing” new drug for stopping her disease in its tracks. Raziel Green, 52, an active runner and mother of two, was diagnosed with a rare form of ALS in 2017.
Congratulations to the members of the Department of Neurology who received accolades through the Supporting a Fair Environment (SAFE) program! SAFE aims to improve the learning environment by promoting positive behaviors and managing concerns about learner mistreatment and unprofessional behaviors. SAFE accolades include treating others with dignity and respect, creating an environment that values diversity, […]
Washington University School of Medicine in St. Louis has received a three-year, $4.5 million grant from the Carol and Gene Ludwig Family Foundation, aimed at advancing research on neuroimmunology and neurodegeneration with the ultimate goal of developing new treatments for Alzheimer’s disease. Administered by WashU Medicine’s Brain Immunology & Glia (BIG) Center, the Carol and […]
Xing “Cathy” Dai, MD, is the newest member of the Adult Neurology Residency Program leadership team at Washington University School of Medicine in St. Louis. She will join Salim Chahin, MD, MSCE, Renee Van Stavern, MD, and Gregory Wu, MD, PhD, as an associate program director, starting July 1, 2025. She began transitioning into the […]
Protein accumulations do important work in the human body, but something can go wrong and proliferate in those aggregates, resulting in neurodegeneration and diseases such as Parkinson’s and Alzheimer’s. One such assembly, amyloid beta peptide, is synonymous with dementia, but researchers were not certain how these peptide assemblies “break bad” and what really causes them […]
Washington University School of Medicine in St. Louis is one of only ten sites in the world participating in a pioneering clinical trial evaluating TSHA-102, an investigational gene therapy for the treatment of Rett syndrome, a severe neurodevelopmental disorder primarily affecting girls. The REVEAL Phase 1/2 clinical trial represents a significant advancement in the quest […]
Jacki Mallmann began her career at Washington University School of Medicine in St. Louis in 1998 as a part-time administrative assistant in the Department of Psychiatry. She spent fourteen years working at the Midwest Alcoholism Research Center, where she gained invaluable administrative research experience by working on multiple NIH-funded studies, IRB submissions, data entry, general […]